TGFB1 and breast cancer: Their conditioned medium directly suppresses T-cell proliferation and impairs the secretion of effector molecules such as interferon-γ (IFN-γ) 36, 102, while autocrine activation of the TGF-β signaling pathway exacerbates metabolic dysregulation in the BC TME 57.